The impact of beta‐blocker therapy on anemia after traumatic brain injury
- 15 March 2012
- journal article
- Published by Wiley in Transfusion
- Vol. 52 (10) , 2155-2160
Abstract
BACKGROUND:An increase in endogenous catecholamine levels after traumatic brain injury (TBI) is well described. Animal studies suggest that postinjury anemia is exacerbated by a persistent hyperadrenergic state. This study aims to determine if beta‐blocker (BB) exposure affects anemia after TBI.STUDY DESIGN AND METHODS:We reviewed a Level I trauma registry for patients with TBI, examining markers of anemia between patients who received BB with those who did not.RESULTS:A total of 174 patients were exposed to BB (BB+) and 245 were not exposed (BB−). The mean age in the BB+ group was 50 years (vs. 36 years in BB− group, p < 0.001). The mean injury severity score was 33.6 for the BB+ group (vs. 30.8 for BB− group, p = 0.01). While BB+ patients were more likely to receive a transfusion (60.9% vs. 35.1%, p < 0.001), BB+ patients reached their nadir hemoglobin (Hb) at a later day of hospitalization and their rate of decrease in Hb was significantly slower (both p < 0.001). Choosing Hb cutoffs for anemia of both 7 and 10 g/dL, Kaplan‐Meier demonstrated a significant delay in time to anemia.CONCLUSION:This study suggests beta‐blockade delays anemia after TBI. Elaboration of this effect may demonstrate an additional benefit of beta‐blockade after head injury.Keywords
This publication has 22 references indexed in Scilit:
- Erythropoietin measurements in severely traumatized patientsActa Anaesthesiologica Scandinavica, 2008
- Beta-Blockers in Isolated Blunt Head InjuryJournal of the American College of Surgeons, 2008
- β-Blocker Exposure in Patients With Severe Traumatic Brain Injury (TBI) and Cardiac UncouplingJournal of Trauma: Injury, Infection & Critical Care, 2007
- Beta-Blocker Exposure is Associated With Improved Survival After Severe Traumatic Brain Injury2007
- β blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure: Table 1Heart, 2006
- Effect of salbutamol, a beta-2-adrenergic agonist, on erythropoietin concentration in healthy malesScandinavian Journal of Medicine & Science in Sports, 2002
- Effect of anaemia and cardiovascular disease on surgical mortality and morbidityThe Lancet, 1996
- Circulating Catecholamines and Sympathetic Activity after Head InjuryNeurosurgery, 1981
- The activity of the sympathetic nervous system following severe head injuryIntensive Care Medicine, 1980
- Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation.Journal of Clinical Investigation, 1977